René Imwinkelried
Chief Executive Officer bei Siegfried Hameln Real Estate GmbH & Co. KG
Profil
René Imwinkelried is currently the Co-Managing Director at Siegfried PharmaChemikalien Minden GmbH and Siegfried Hameln Real Estate GmbH & Co. KG.
Previously, he worked as the Head-Research & Development at Siegfried Holding AG from 2012 to 2020.
Prior to that, he was the Head-Technical Development Small Molecules at Roche Group from 2010 to 2012.
He also served as the Head-Chemical Division at Schering-Plough Ltd.
Additionally, he worked as the Head-Global Chemical & Physical Sciences at Lonza AG from 1991 to 2004.
Dr. Imwinkelried holds a doctorate degree from the Swiss Federal Institute of Technology.
Aktive Positionen von René Imwinkelried
| Unternehmen | Position | Beginn |
|---|---|---|
Siegfried Hameln Real Estate GmbH & Co. KG
 Siegfried Hameln Real Estate GmbH & Co. KG Real Estate DevelopmentFinance Part of Siegfried Holding AG, Siegfried Hameln Real Estate GmbH & Co. KG provides real estate services. The private company is based in Hameln, Germany. The CEOs of the German company are Arnoud Michael Middel, René Imwinkelried. | Chief Executive Officer | - |
Siegfried PharmaChemikalien Minden GmbH
 Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The private company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von René Imwinkelried
| Unternehmen | Position | Ende |
|---|---|---|
| SIEGFRIED HOLDING AG | Chief Operating Officer | 31.12.2020 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.09.2012 |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Corporate Officer/Principal | 01.01.2004 |
Schering-Plough Ltd.
 Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von René Imwinkelried
| Swiss Federal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIEGFRIED HOLDING AG | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Schering-Plough Ltd.
Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Health Technology |
Lonza AG
Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Health Technology |
Siegfried PharmaChemikalien Minden GmbH
Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The private company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried. | Process Industries |
Siegfried Hameln Real Estate GmbH & Co. KG
Siegfried Hameln Real Estate GmbH & Co. KG Real Estate DevelopmentFinance Part of Siegfried Holding AG, Siegfried Hameln Real Estate GmbH & Co. KG provides real estate services. The private company is based in Hameln, Germany. The CEOs of the German company are Arnoud Michael Middel, René Imwinkelried. | Finance |
